Altrafin AG
- SEC CIK
- 0002110313
- Latest filing
- Jul 20, 2026
BMY holding history
Bristol Myers Squibb Co in every 13F filed by Altrafin AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMY overviewAll 13F holders of BMYFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −11,000−100.0% | Sold out | Holders |
| Q3 2023 | 11,000 | $638.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2023 | 11,000 | $703.5K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2023 | 11,000 | $762.4K | 0.4% | −200−1.8% | Reduced | Holders |
| Q4 2022 | 11,200 | $805.8K | 0.5% | 00.0% | Unchanged | Holders |
| Q3 2022 | 11,200 | $796.2K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2022 | 11,200 | $862.4K | 0.5% | −27,000−70.7% | Reduced | Holders |
| Q1 2022 | 38,200 | $2.79M | 1.1% | +200+0.5% | Added | Holders |
| Q4 2021 | 38,000 | $2.37M | 0.9% | – | No prior filing | Holders |